Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-30 @ 12:12 AM
Study NCT ID:
NCT01644968
Status:
COMPLETED
Last Update Posted:
2022-05-17
First Post:
2012-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Sponsor:
Providence Health & Services
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
ACTUAL
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-17
First Submit QC Date:
None
Study First Post Date:
2012-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-16
Last Update Post Date:
2022-05-17
Last Update Post Date Type:
ACTUAL